Report ID: SQSG35H2019
Biopharmaceuticals Contract Manufacturing Market Size, Share, Growth Analysis, By Source(Mammalian, Non-mammalian), By Service(Process Development, Fill & Finish Operations, Packaging, others), By Product Type(Interferon, Monoclonal Antibodies, Protein, Vaccines), By Therapeutic Applications(Oncology, Cardiovascular Diseases, Others), By Region - Industry Forecast 2024-2031
Report ID:
SQSG35H2019 |
Region:
Global |
Published Date: April, 2024
Pages:
157
|
Tables:
120 |
Figures:
77
Biopharmaceuticals Contract Manufacturing Market Competitive Landscape
Global biopharmaceuticals contract manufacturing market is consolidated in nature with the presence of several large market players operating across the globe. And, in terms of market share, top 5 players of the market are dominating the market including Boehringer Ingelheim, JSR Pharma, and Inno Biologics Sdn Bhd. These players are highly focusing on few business developing strategies including collaborations, mergers, new product innovations, and advance technology adoption to expand their geographical presence and product offerings.
Biopharmaceuticals Contract Manufacturing Market Top Player’s Company Profiles
- Boehringer Ingelheim GmbH
- Catalent
- Lonza Group AG
- Thermo Fisher Scientific Inc.
- Samsung BioLogics Co. Ltd.
- Fujifilm Diosynth Biotechnologies
- WuXi Biologics (Cayman) Inc.
- AbbVie Inc.
- AGC Biologics
- Baxter BioPharma Solutions
- Biocon Ltd.
- Cytovance Biologics Inc.
- Eurofins Scientific SE
- Genscript Biotech Corporation
- Grifols SA
- Innovent Biologics (Suzhou) Co. Ltd.
- JSR Corporation
- KBI Biopharma Inc.
- Merck KGaA
- Novasep Holding SAS
Biopharmaceuticals Contract Manufacturing Market
Biopharmaceuticals Contract Manufacturing Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
